Fennec Pharmaceuticals Inc. (TSE:FRX – Get Rating) – Stock analysts at Wedbush issued their FY2027 earnings per share (EPS) estimates for shares of Fennec Pharmaceuticals in a research report issued to clients and investors on Thursday, May 11th. Wedbush analyst D. Nierengarten forecasts that the biopharmaceutical company will post earnings of $3.38 per share for […]